Healthcare · Vaccine antigens production

Vaccine antigens production in Brazil in 2026

Brazil is a key player in global vaccine production, ranking 3rd out of 197 countries. In 2026, the volume of vaccine antigen production reached 400 million doses. The country has historically been strong in this sector thanks to the Butantan Institute in São Paulo and the Oswaldo Cruz Foundation (Fiocruz) in Rio de Janeiro — these centers have been developing and producing vaccines for the national immunization program, one of the largest in the world, for decades. However, export figures remain modest due to a focus on the domestic market.

Data for 2026 · unit: million doses
Position

Brazil world ranking

#3 / 197

Country position on the scale from last to first place for this indicator.

BR
#3
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
50
1990
100
2000
200
2010
350
2020
400
2025
400
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Brazil — how much?
Based on 2026 data — 400 million doses. This is rank #3 out of 197 countries.
What is Brazil's rank by Vaccine antigens production?
Brazil ranks #3 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Brazil?
Over the available period the indicator changed from 1 to 400 million doses.